Background--Mammalian SWItch/Sucrose NonFermentable (SWI/SNF) adenosine triphosphate (ATP)-dependent chromatinremodeling complexes play important roles in embryonic vascular development by modulating transcription of specific target genes. We sought to determine whether SWI/SNF complexes likewise impact postnatal physiological and pathological angiogenesis.
M
ammalian SWItch/Sucrose NonFermentable (SWI/SNF) adenosine triphosphate (ATP)-dependent chromatin remodeling complexes impact a number of developmental processes by modulating transcription of target genes. 1, 2 These multiprotein complexes utilize energy derived from ATP hydrolysis to transiently displace nucleosomes in gene-regulatory regions and thereby impact the ability of large transcriptional machinery to access DNA. 3, 4 SWI/SNF chromatin-remodeling complexes contain 1 of 2 catalytic ATPases, which are critical for their assembly and function: Brahma (Brm) and Brahma-related gene 1 (Brg1). Genetic mutation of these ATPases in mice has revealed their disparate functions. Brm À/À mice are viable, 5 but Brg1 À/À embryos die at the periimplantation stage of development. 6 Conditional inactivation of Brg1 in the early embryonic vasculature has revealed roles for this enzyme in various aspects of blood vessel development. Deletion of Brg1 with the endothelial and hematopoietic cell-specific Tie2-Cre transgenic (Tg) line has yielded information about roles for BRG1 in promoting yolk sac vascular Wnt signaling, 7 embryonic and extraembryonic venous specification, 8 and cardiac trabeculation. 9 However, death of Brg1 fl/fl ; Tie2-Cre embryos at embryonic day 10.5 (E10.5) from defective primitive erythropoiesis 10 has prevented evaluation of the contribution of BRG1 to vascular development beyond midgestation.
Most vasculature is quiescent after birth, although some notable exceptions exist. For example, physiological angiogenesis occurs in the neonatal rodent retina, 11 human female reproductive tract during ovulation and menstruation, 12, 13 uterus and placenta during pregnancy, 14 and skeletal muscle after exercise. 15 Physiological angiogenesis also occurs during bone growth, 16 wound healing, 17 and tissue repair. 18 Pathological angiogenesis can occur in the diabetic retina, 19 joints of patients with rheumatoid arthritis, 20 skin of patients with psoriasis, 21 and patients with hematological malignancies 22 and solid tumors. 23 Many of the same gene programs that contribute to embryonic vascular development are recapitulated during postnatal physio-and pathological angiogenesis. For example, vascular endothelial growth factor and Notch signaling impact embryonic vascular development as well as postnatal retinal and tumor angiogenesis. 24, 25 However, chromatin-based mechanisms regulating these and other signaling pathways have been largely underexplored during postnatal vascular development. Specifically, it is unclear whether SWI/SNF chromatin-remodeling complexes are required for postnatal angiogenesis under physiological or pathological conditions. In order to determine whether SWI/SNF complexes impact postnatal angiogenesis, we assessed conventional, conditional, and inducible genetic mutants of Brg1 and Brm using 3 different models of postnatal angiogenesis. To our surprise, we found no evidence of a role for BRG1 or BRM during neonatal retinal vascular growth, exercise-induced angiogenesis in quadriceps muscles of adult mice, or tumor angiogenesis in adult mice. However, infant mice deficient in both BRG1 and BRM die before weaning, with bleeding in the small intestine and heart. These findings illuminate the temporal specificity with which SWI/SNF complexes regulate vascular development and implicate other chromatin-remodeling complexes in transcriptionally regulating the genes that are required to drive postnatal angiogenesis.
Methods Mice
Brg1-floxed mice (Brg1 fl/fl ), 26 Brm null mice (Brm À/À ), 5 cVECad-Cre Tg mice, 27 Cdh5(PAC)-Cre ERT2 Tg mice, 28 and
ROSA26R
LacZ Tg mice 29 were maintained on a mixed genetic background at the Oklahoma Medical Research Foundation (Oklahoma City, OK) animal facility. All animal use protocols were approved by the institutional animal care and use committee. Brg1-floxed, Brm À/À , and ROSA26R LacZ mice were genotyped as previously described. 7, 10, 29 cVECad-Cre Tg mice were polymerase chain reaction (PCR) genotyped by amplifying a 300-base-pair (bp) fragment of the transgene using a gene-specific forward primer (5 0 -GCAGGCAGCTCACAAAGG AACAAT-3 0 ) and a Cre recombinase-specific reverse primer were fed by placing a pipette tip on their tongues until they voluntarily ingested 2 lL (25 mg/mL) of tamoxifen. Animals were fed at postnatal day 3 (P3), P4, and P5. Tamoxifen was dissolved in a mixture of 95% peanut oil and 5% ethanol and sonicated as previously described, 30 and all control and mutant animals were treated with tamoxifen for each study.
Immunohistochemistry
Tissues were fixed with 4% paraformaldehyde (PFA) overnight at 4°C and then transferred to 70% ethanol overnight at 4°C. Tissues were then paraffin embedded and sectioned on a microtome (8 lm After a brief wash in PBS, heart and quadriceps tissues were placed in 70% ethanol overnight at 4°C and then paraffin embedded. Paraffin blocks were sectioned (20 lm) and then counterstained with nuclear fast red.
Retina Studies
Whole eyes from P7 pups were enucleated and placed in 4% PFA for 20 minutes and then washed with PBS. Retina cups were dissected out and hyaloid vessels were carefully removed, as previously described. 31 Retina cups were fixed again with 4% PFA for 1 hour at room temperature, then washed and placed in methanol for storage at À20°C. For isolectin staining, retinas were removed from methanol, rehydrated by washing in PBS, and blocked in Block/ Permeabilization buffer (1% BSA and 0.5% Triton X-100 in PBS) overnight at 4°C. For retina studies, all annotation was blinded, and fields were chosen at random throughout the entire retina. For measuring distance between the vascular front and the end of each retina, measurements were made using NIS-Elements AR3.0 software (Nikon, Melville, NY), and 4 measurements were taken for each retina. For counting vascular branches, every branch was counted by hand in 10 fields for each retina, and values were averaged together. For quantifying vascular sprouting, every sprout was counted by hand in 10 fields for each retina. For measuring vascular branch width, NISElements AR3.0 software (Nikon) was used to measure 10 random branch widths in 10 fields for each retina. All values were then averaged together.
Exercise Studies
Eight-week-old male mice were used for all exercise studies. Exercised animals were housed in customized cages containing an exercise wheel (4.5 inch diameter, Catalog No.: 610-0003-00; Mini Mitter, Bend, OR) and a probe and digital activity counter that recorded wheel rotations (Catalog No.: 199-0048-00, ResKit Magnetic Switch Custom; Catalog No.: 130-0023-00, Digital Activity Counter; Mini Mitter). Before the experiment, animals were allowed to habituate to the cages for 3 days, with the wheel locked in a stationary position. After habituation, the wheel was released, and animals were allowed to run voluntarily for 3 weeks. Wheel rotations were recorded daily during the exercise period (0.36 m/wheel revolution). For studies with Brg1 fl/fl ;Cdh5(PAC)-Cre ERT2 animals, control and mutant male mice received 5 tamoxifen injections (every other day) beginning at 6 weeks of age followed by 3 days of habituation and 3 weeks of exercise. Sedentary animals were induced comparably to exercised animals, but were housed in cages without wheels for the duration of the study. Immediately after animals were euthanized, quadriceps muscles were removed from exercised and sedentary mice. Muscles were washed with PBS and immediately placed in 30% sucrose/PBS overnight at 4°C. Quadriceps muscles were then cryoembedded, and transverse sections (8 lm) were cut from proximal, medial, and distal regions of the total muscle.
Sections were fixed in 4% PFA for 10 minutes at room temperature and blocked using the Streptavidin/Biotin Blocking Kit (Vector Laboratories), according to the manufacturer's instructions. Sections were washed with wash buffer (PBS/0.1% Triton X-100) and blocked with 3% normal goat serum, 0.3% Triton X-100, and 3% BSA in 19 PBS for 1 hour at room temperature. Sections were then incubated with antiplatelet endothelial cell adhesion molecule 1 (PECAM-1; 1:100; Catalog No.: 557355; BD Biosciences, San Jose, CA) diluted in PECAM staining buffer (1% normal goat serum, 0.1% Triton X-100, and 1% BSA in 19 PBS) overnight at 4°C. After washing with wash buffer, sections were stained with Biotinylated Goat Anti-Rat IgG (1:500; Catalog No.: BA-9400; Vector Laboratories) secondary antibody for 30 minutes at room temperature protected from light. Sections were washed with wash buffer and then stained with DyLight 594-Streptavidin (1:500; Catalog No.: SA-5594-1; Vector Laboratories) for 5 minutes at room temperature protected from light. After another wash, sections were again blocked with the Streptavidin/Biotin Blocking Kit, according to the manufacturer's instructions, and then blocked with 3% normal donkey serum, 0.3% Triton X-100, and 3% BSA in 19 PBS for 1 hour at room temperature protected from light. Sections were stained with anti-laminin antibody (1:500; Catalog No.: ab14055; Abcam, Cambridge, MA) diluted in laminin staining buffer (1% normal donkey serum, 0.1% Triton X-100, and 1% BSA in 19 PBS) for 30 minutes at room temperature protected from light. After washing, sections were stained with Donkey Anti-Chicken DyLight 488 antibody (1:500; Catalog No.: 703-485-155; Jackson ImmunoResearch, West Grove, PA) for 30 minutes at room temperature protected from light. Slides were then washed with wash buffer, washed again in PBS to remove the Triton X-100, mounted with DABCO (in 9:1 glycerol/PBS [pH 8.6]), and fluorescent images were taken immediately. For exercise studies, all annotation was blinded. Ten random fields were chosen for analysis in the center of each muscle section, where the vasculature is most receptive to exercise-induced angiogenesis. 32 Muscle fibers and blood vessels in each section were counted by hand. Sections from the proximal, medial, and distal regions of the quadriceps muscle from each animal were stained independently, and values were averaged together. (double-mutant) LLC mice after 3 weeks or once tumors reached 2 cm in size. After 10 minutes, the animal was sacrificed and the tumor was immediately removed and placed in 4% PFA overnight at 4°C. Fixed tumors were then cryoembedded, sectioned (8 lm), and costained with anti-PECAM-1, as described above, for fluorescent imaging.
Lewis Lung Carcinoma Tumor Studies

Fluorescent Imaging
Fluorescent images were obtained with a Nikon Eclipse 80i microscope, an X-cite 120Q light source, and a Nikon DSQi1Mc camera. NIS-Elements AR3.0 (Nikon) software was used for all fluorescent image acquisition and annotation.
Statistical Analysis
All graphs were generated and statistical analyses were performed using GraphPad Prism software (6; GraphPad Software Inc., La Jolla, CA). Individual study designs and sample sizes are described in the figure legends. Data are presented as the meanAESEM. All statistics were generated using an unpaired, 2-tailed Student t test. A probability of P<0.05 was considered to be statistically significant.
Results
Postnatal Vascular Brg1 Excision
Given that deletion of Brg1 with an endothelial Tie2-Cre Tg line results in embryonic lethality at midgestation, 9,10 we used 2
E15.5 BRG1
Brg1 samples of heart, quadriceps, and retina from ROSA26R LacZ control animals or ROSA26R LacZ ;Cdh5(PAC)-Cre ERT2 mutants were whole-mount X-gal stained (blue) to detect Cre activity and sectioned. Heart and quadriceps tissues were counterstained with nuclear fast red. Scale bar=50 lm. C, BRG1 expression (brown) in blood vessels of control (Brg1 fl/fl ) and mutant (Brg1 flfl ;Cdh5(PAC)-Cre ERT2 ) adult LLC tumors. Sections were counterstained with hematoxylin (blue). Arrows denote endothelial cells with BRG1 expression; asterisks highlight endothelial cells with reduced BRG1 expression. Scale bar=50 lm. D, PCR genotyping of DNA isolated from tail clips of a litter of P7 pups (lanes 1 to 11) generated from a cross between a Brg1 fl/fl female and a Brg1 fl/fl ;Cdh5(PAC)-Cre ERT2 male. Top image shows PCR products using primers to detect Cdh5(PAC)-Cre ERT2 , and bottom image shows PCR products using primers to detect a Brg1 fl/fl excision event (Brg1D, top band) and an internal control gene to validate sample quality (Tcrd gene; bottom band). Tissue from a Brg1 fl/+ ;Cdh5(PAC)-Cre ERT2 animal and sample lysis buffer are included as positive and negative controls, respectively. E, PCR on DNA isolated from various tissues of a 14-week-old Brg1 ) and mutant (Brg1 fl/fl ;cVECad-Cre) E15.5 jugular veins for BRG1. We found a modest number of ECs with diminished or depleted BRG1 staining using this technique ( Figure 1A, top) , indicating that the cVECad-Cre line excised BRG1 with mixed efficiency in embryonic ECs. We also evaluated Brg1 excision with this Cre line in a postnatal setting by staining for BRG1 in LLC tumors. We found robust EC excision of Brg1 in this model ( Figure 1A , bottom).
As an alternative to the cVECad-Cre line, we also employed a tamoxifen-inducible Cdh5(PAC)-Cre ERT2 line to excise Brg1 in postnatal vasculature. This line has been used extensively for deleting genes in postnatal ECs. 28, [33] [34] [35] [36] [37] In our hands, reporter analysis with this line confirmed efficient Cre activity in blood vessels within the heart, quadriceps, and adult retina ( Figure 1B ). To confirm that Brg1 could be excised with this line, we stained for BRG1 in LLC tumors from control and ;Cdh5(PAC)-Cre ERT2 ) animals at P3, P4, and P5 and performed PCR for a Brg1 deletion product on tail clips harvested at P7. All of the animals carrying the Cre showed the Brg1 deletion product, and none of the Crenegative pups showed the deletion product ( Figure 1D ). In addition, we assessed Brg1 excision in various tissues harvested from a 14-week-old Brg1
animal that had been induced with tamoxifen at 4 weeks of age. PCR analysis again showed Brg1 excision in all the tissues we analyzed ( Figure 1E ). Therefore, the Cdh5(PAC)-Cre ERT2 line is capable of excising Brg1 in pups and mature mice after tamoxifen treatment.
Vascular BRG1 and BRM Are Not Required for Neonatal Retinal Angiogenesis
With 2 different methods of achieving postnatal vascular Brg1 excision in hand, we proceeded to study the effects of SWI/ SNF ATPases on retinal vascular development. From birth until P7, blood vessels gradually extend in a two-dimensional sheet from the optic nerve toward the periphery in mice. 31 Because these vessels can be easily visualized by staining with isolectin B4 (IB4) and flat mounting, the retina is an excellent model for studying neonatal vascular development. littermates after tamoxifen induction at P3 to P5. Using these 4 cohorts of control and mutant genotypes, we made 4 separate measurements on a single retina from each animal analyzed (8 to 11 animals per genotype). First, we measured the distance from the edge of the vascular front to the edge of the retina, as a general readout of the rate of vascular growth ( Figure 2A ). Second, we counted vascular branches in 10 separate fields from each retina analyzed ( Figure 2B ). Third, we counted vascular sprouts in 10 separate fields from each retina ( Figure 2C) . And, finally, we measured the width of 10 random vessels in 10 separate fields from each retina ( Figure 2D ). We found no significant differences in any of the retinal vascular measurements we made, with the exception of a slight decrease in vascular branching in Brg1 Figure 2 . SWI/SNF mutants do not display major vascular defects in the neonatal retina. Retinas from postnatal day 7 (P7) pups were stained with isolectin B4 and flat mounted to visualize the vasculature. A, Distance (lm) was measured from the edge of the vascular front to the end of the retina (white bar). Four measurements were made for each retina. B, Retina vascular branches (white dots) were counted in 10 fields for each retina. C, Vascular sprouts (white circle) were counted in 10 fields for each retina. D, Branch widths were measured from 10 vessels in 10 different fields for each retina. P19. The most striking phenotype associated with these double mutants, and the likely cause of their death, was massive hemorrhage that occurred in the small intestine. We saw blood filling the lamina propria of the ileum of all dead and dying double mutants that we evaluated ( Figure 3A) . We also detected hemorrhage in the hearts of dead and dying double-mutant pups ( Figure 3B) 
Vascular BRG1 and BRM Do Not Individually Contribute to Exercise-Induced Angiogenesis in Adult Quadriceps
Exercise is a powerful physiological trigger for angiogenesis in adult animals. 39 The quadriceps femoris muscle is a convenient model for studying exercise-induced angiogenesis in mice because it can undergo up to a 2-fold increase in capillary density after voluntary wheel running. 32 In order to determine whether SWI/SNF chromatin remodeling influences this physiological angiogenesis process, we examined 3 groups of age-matched, male control and mutant animals: WT and Brm À/À . In each case, 8-week-old male mice that were slated for exercise were habituated in a cage with a locked exercise wheel for 3 days. After 3 days, the wheel was unlocked and animals were allowed to run voluntarily for 3 weeks. Wheels were attached to an external activity monitor, which recorded the total distance run each night. No significant differences in distances run were observed between the control and mutant genotypes within each cohort ( Figure 4A through 4C, left panels). Age-matched sedentary animals of each genotype were housed in cages without running wheels for the course of the exercise study to provide a baseline for assessing angiogenesis. Four to 6 sedentary and exercised animals were assessed for each control and mutant genotype analyzed. For the studies involving animals carrying the Cdh5(PAC)-Cre ERT2 transgene, control and mutant sedentary and exercised mice were induced with tamoxifen every other day for 5 injections starting at 6 weeks. To assess angiogenesis, quadriceps muscles were harvested from euthanized mice after 3 weeks of sedentary or running activity. Transverse muscle sections were stained with antibodies against PECAM-1 for visualizing blood vessels and against laminin for outlining muscle fibers ( Figure 4A through 4C, middle panels). Sections from proximal, medial, and distal regions of the quadriceps were stained from each animal, and vessels and fibers were counted in 10 fields from each stained section ( Figure 4A through 4C, right panels). We saw significantly more vessels per fiber for exercised versus sedentary animals, indicating that exercise-induced angiogenesis occurred in all genotypes. However, we saw no significant differences in the magnitude of the angiogenic response between control and mutant animals for exercised animals in the 3 different cohorts. Therefore, vascular BRG1 and BRM appear not to be required-at least independently-for exercise-induced angiogenesis. 
;Brg1
fl/fl (control), and Brm À/À ;Brg1 fl/fl ;Cdh5(PAC)-Cre ERT2 (double-mutant) ilea were hematoxylin and eosin stained. Hemorrhage is seen in the lamina propria (L.P.) of the double-mutant ileum. B, Control and double-mutant tissues from postnatal day 14 (P14) pups were stained with hematoxylin and eosin. Top images show hemorrhage in the intramuscular tissue of the double-mutant heart (arrows). No hemorrhage was detected in double-mutant kidney, liver, or lung tissues. C, Control and double-mutant tissues from P14 pups were immunostained for BRG1 (brown) and counterstained with hematoxylin (blue). Arrows point to endothelial cells that express BRG1. Asterisks highlight endothelial cells where BRG1 expression is diminished. Scale bars=50 lm (A and B) ; 100 lm (C). A indicates artery; Brg1, Brahma-related gene 1; Brm, Brahma; V, vein. to visualize cell nuclei. Eleven to 21 animals from each genotype were analyzed. We saw no quantitative differences in tumor growth rates between any of the sets of mutant and control animals ( Figure 5 , left panels). Likewise, we saw no qualitative differences in vascular density or morphology in any of the tumor sections ( Figure 5 , right panels). In addition, Brm/Brg1 double-mutant mice that were intravenously injected with FITC/dextran before being sacrificed, showed no evidence of vascular leakage ( Figure 5 , bottom right panel). Therefore, vascular BRG1 and BRM do not play significant individual or redundant roles in LLC tumor growth and angiogenesis.
Discussion
BRG1 impacts angiogenesis in the midgestation embryo by promoting Wnt signaling and venous specification. 7, 8 We predicted that BRG1 would likewise perform these and other functions during postnatal vascular growth. This prediction was based, in part, on the finding that BRG1 can recapitulate its developmental cardiac gene regulatory roles in a postnatal pathological context. 40 During embryonic development, BRG1
helps to promote transcription of the embryonic form of myosin heavy chain (b-MHC) and repress transcription of the adult form (a-MHC). Because BRG1 expression is downregulated after birth, myocardial cells switch their MHC production from the embryonic to the adult form. However, when the adult heart is stressed, BRG1 expression is reelevated and once again represses a-MHC and activates b-MHC, as it did in the embryo, thereby contributing to hypertrophic cardiomyopathy. In the current study, we used mice with Brg1 deleted from vascular ECs (VECs) to look for similarly repetitive roles for BRG1 in embryonic and postnatal vascular development. However, we did not find evidence that BRG1 is essential for promoting vascular development in the neonatal retina, exercise-stimulated quadriceps, and solid tumors (summarized in Table 2 ). The reason for this discrepancy between embryonic and postnatal roles for BRG1 in developing vasculature is unclear. It is possible that the 2 endothelial Cre lines we used did not excise Brg1 sufficiently to elicit phenotypes in the tissues we studied. The mosaic pattern of BRG1 expression in postnatal endothelium and its widespread expression in other cell types makes it difficult to quantify endothelial Brg1 excision efficiently. However, the lethality that we observe when Brg1 is excised with either cVECadCre arteriovenous anastomoses, and intraocular hemorrhages. 41 However, we did not see any such phenotype in the retinas of our postnatal vascular Brg1 mutants. Therefore, it is possible that BRG1 does not regulate transcription of Fzd4 in postnatal retinal ECs or that the level of reduction of Fzd4 in our postnatal Brg1 mutants is not dramatic enough to yield retinal vascular phenotypes. Likewise, we previously showed that BRG1 promotes expression of the nuclear receptor, Coup-TFII, which drives venous specification. 8 Postnatal global deletion of Coup-TFII reduces tumor angiogenesis and tumor growth in multiple mouse tumor models, including the LLC tumor model. 42 Therefore, our lack of tumor angiogenesis phenotypes in Brg1 vascular mutants using the LLC model may indicate that BRG1 does not promote Coup-TFII in tumor vasculature. On the other hand, it is possible that Coup-TFII expression is not essential in tumor ECs to promote tumor angiogenesis, but is more important in tumor stromal cells for the production of the angiogenic growth factor, angiopoietin-1.
42
Simultaneous deletion of Brg1 and Brm did not yield retinal or tumor angiogenesis defects either, indicating that the enzymes do not play necessary and redundant roles in these angiogenic processes. However, we saw striking hemorrhage in the small intestine and hearts of Brm/Brg1 double-mutant infant mice, which correlated with lethality. We found BRG1 to be expressed in ECs from a variety of tissues in P14 mice, although its expression was typically mosaic within ECs of a single vessel. However, BRG1 appeared to be expressed more consistently in ECs of the ileum, where we saw the most profound bleeding. We do not have a specific antibody to assess BRM staining in mouse tissues, but our phenotypic data indicate that BRM is likewise expressed in ileum and heart vascular endothelium, where it plays a critical role, together with BRG1, in maintaining vascular integrity in infant mice. The temporal and spatial specificity of this role for BRG1 and BRM in maintaining vascular integrity is consistent with similarly specific roles attributed to SWI/SNF complexes in embryonic vasculature. For example, we found that yolk sac vascular Wnt signaling is more impacted by Brg1 deletion at midgestation than embryonic vascular Wnt signaling. 7 Such specificity may be impacted by redundant roles of other ATPdependent chromatin remodelers or by tissue-specific expression of cofactors required for SWI/SNF recruitment and activity at target genes. 43 We acknowledge the possibility that the 3 models of postnatal vascular growth we analyzed-physiological angiogenesis in the neonatal retina, exercise-induced angiogenesis in the adult quadriceps, and tumor angiogenesis in an LLC tumor model-may not require SWI/SNF ATPases, but that BRG1 and BRM may play critical roles in other postnatal angiogenesis contexts. Anecdotally, we know that BRG1 is not essential for angiogenesis associated with pregnancy, given that Brg1 fl/fl ; cVECad-Cre females are able to give birth to normal-sized litters. However, if SWI/SNF complexes do impact angiogenesis in alternative contexts, such as wound healing or retinopathy, it would be consistent with their spatially specific actions in embryonic vasculature at midgestation.
Altogether, the current work provides surprising evidence that SWI/SNF chromatin-remodeling complexes do not play critical roles in multiple models of postnatal physio-and pathological angiogenesis. However, the complexes do play a critical role in maintaining vascular integrity in ileum and heart of infant mice. This extends our understanding of the temporal and spatial specificity these remodeling complexes utilize in choosing their target genes. Future investigations will be focused on investigating other chromatin-remodeling complexes or combinations of complexes that may regulate fundamental genes and signaling pathways involved in postnatal vascular development.
